Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

Published on 6 May 2024 on Benzinga via Yahoo Finance

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

On Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2 PAVIA trial evaluating Duravyu (vorolanib intravitreal insert), previously known as EYP-1901, in patients with non-proliferative diabetic retinopathy (NPDR).

The data demonstrated that Duravyu has a biologic effect in patients with NPDR and a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint.

Read the rest of the article

NASDAQ.EYPT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com

Tuesday, Mizuho adjusted its outlook on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), slashing th...

Investing.com 7 May 2024

Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge - Spirit Airlines (NYSE:SAVE)

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 1...

Benzinga 6 May 2024

EyePoint reports mixed results in diabetic retinopathy trial By Investing.com

EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) announced interim results from its Phase 2...

Investing.com 6 May 2024

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving...

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of S...

Benzinga 6 May 2024

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's...

Shares of Perficient, Inc PRFT shares rose sharply during Monday's session after the company disc...

Benzinga 6 May 2024

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday? On Monday, EyePoint Pharmaceuticals I...

Benzinga via Yahoo Finance 6 May 2024

EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal

dropped nearly 30% in premarket trading Monday after the company said its experimental...

Market Watch 6 May 2024

EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)

EyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Pha...

Seeking Alpha 6 May 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.46%

Investing.com 6 May 2024

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By...

One thing we could say about the analysts on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - they ...

Simply Wall St. via Yahoo Finance 9 Mar 2024

News

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

NASDAQ.EYPT price evolution

Want to become a better investor?